Startups

Prellis Biologics raises $14.5M, debuts a ‘human immune system’ in a dish

Comment

Image Credits: PIXOLOGICSTUDIO/SCIENCE PHOTO LIBRARY / Getty Images

Prellis Biologics, a company developing the tools to create 3D-printed organs, announced a $14.5 million Series B round on Wednesday. Prellis has spent years developing tissue engineering capacity, but has focused recently on developing one type of structure in particular.

Up until this point, Prellis has focused on 3D printing vascular scaffolds that would allow companies to grow healthy and oxygenated human organs (or miniature versions, called organoids) for drug testing, and eventually transplant. But the company has recently debuted a new product, called EXIS (short for Externalized Immune System): a lab-grown version of a human lymph node. 

Lymph nodes are critical parts of the human immune system — they store certain immune cells, and help the body manufacture immune responses. Ideally, those lymph node organoids would aid in drug development by mimicking how a person’s immune system might respond to new treatment. And, perhaps, help create some new drugs along the way. 

“By creating this immune system in a dish, we can actually test if those therapeutics are going to elicit an immune response before it goes into a human,” founder and CEO Melanie Matheu told TechCrunch. 

“Our company’s edge is that [EXIS] is out of the box fully human.” 

Prellis Biologics, founded in 2016, has raised about $29.5 million to date. This Series B round was led by Celesta Capital and existing investor Khosla Ventures, with participation from SOSV IndieBio. In addition, the company will add Kevin Chapman, Celesta advisor and former CSO of Berkeley Lights, as chief scientific officer. Yelda Kaya, formerly of J&J Innovation, will join as chief business officer. 

Lymph node responses to drugs or pathogens has been recognized as a way to predict how the whole immune system might react. Correspondingly, there are a number of academic labs working on developing in-vitro models of human lymph nodes — from lymph nodes on chips to growing lymphoid organoids from tonsil tissue

Prellis has entered the fray by using its scaffolds to facilitate oxygen and nutrient exchange needed to grow functioning lymph node organoids. This method, Matheu says, allows Prellis to “replicate the human immune system outside the human.” 

This focus on the lymph node, in turn, opens up a new angle for the company: antibody drug development.

Developing new antibody treatments and predicting how they’ll work in clinical tests is becoming a more competitive space, and there are a few different approaches underway.

Some are computational. Nabla Bio, which just raised $11 million, has used natural language processing to design antibodies. Generate Bio, which just raised a $370 million Series B, has also used a machine learning approach. 

Prellis’ approach is to model the immune system in miniature and develop a cadre of drug candidates by mining immune responses. Matheu calls it “natural intelligence” as opposed to artificial intelligence. 

The company can create 1,200 organoids from one blood draw, challenge those immune systems with a particular antigen, and see what each immune system comes up with. That process, she says, can be done with different blood donors with different immune system characteristics to create a plethora of responses to analyze. 

“It’s very rare that all 10 of those people are going to come up with the same antibody solution to the problem of: does it bind this protein? And so from a given human, we’re averaging anywhere from 500 to 2,000 unique antibodies, and then you just multiply that by the number of people, and these are all target binding antibodies.” 

It takes about 18 days to go from blood draw to “antibody library,” per materials provided by Prellis Biologics. 

Image Credits: Prellis Biologics

Matheu says the company has developed antibodies responsive to SARS-CoV-2, Influenza A and Marburg Hemorrhagic Fever (these results haven’t been published). The company is developing partnerships with five drug companies, though Matheu declined to name which ones. 

The company plans to use this round to move from an R&D driven company to a product focused one — which means developing more drug partnerships, and demonstrating the platform’s capability. 

The major marker of success, she says, would be to bring an antibody treatment into the clinic. That may occur through collaboration with a pharmaceutical partner, though the company hasn’t ruled out creating a drug pipeline of its own. 

Matheu is light on specifics, but says Prellis is developing “internal technology” that would support a therapeutic pipeline. 

“I will say, we will move in that direction as the technology develops,” she said. 

 

*This story has been updated to reflect that Prellis is developing partnerships with drug companies, but has not yet entered into them and to include mention of investor SOSV IndieBio.

More TechCrunch

The security firm said the attacks targeting Snowflake customers is “ongoing,” suggesting the number of affected companies may rise.

Mandiant says hackers stole a ‘significant volume of data’ from Snowflake customers

French startup Kelvin, which uses computer vision and machine learning to make it easier to audit homes for energy efficiency, has raised $5.1M.

Kelvin wants to help save the planet by applying AI to home energy audits

A last call and a major shoutout to any and all early-stage founders. It’s time to dig deep and take advantage of an unparalleled opportunity at TechCrunch Disrupt 2024 —…

Only hours left to apply to Startup Battlefield 200 at Disrupt

Privacy watchdogs in the U.K. and Canada have launched a joint investigation into the data breach at 23andMe last year.  On Monday, the U.K,’s Information Commissioner’s Office (ICO) and the…

UK and Canada privacy watchdogs investigating 23andMe data breach

Dubai-based fractional property investment platform Stake has raised $14 million in Series A funding.

Stake raises $14M to bring its fractional property investment platform to Saudi Arabia, Abu Dhabi

“We were motivated to fundraise because we think the ’24 vintage is going to be a good one,” founder Craig Shapiro said.

After hits like Reddit and Scopley, Collaborative Fund easily raised a $125M fund to tackle climate, health and food

The merger has yet to close due to extended due diligence amid ongoing restructuring and macroeconomic headwinds across multiple countries.

Sources: Wasoko-MaxAB e-commerce merger faces delays amid headwinds in Africa

The keynote will be focused on Apple’s software offerings and the developers that power them, including the latest versions of iOS, iPadOS, macOS, tvOS, visionOS and watchOS.

Watch Apple kick off WWDC 2024 right here

Featured Article

What to expect from WWDC 2024: iOS 18, macOS 15 and so much AI

Apple is hoping to make WWDC 2024 memorable as it finally spells out its generative AI plans.

6 hours ago
What to expect from WWDC 2024: iOS 18, macOS 15 and so much AI

While funding for Italian startups has been growing, the country still ranks eighth in Europe by VC investment, according to Dealroom. Newly created Italian Founders Fund (IFF) hopes to help…

With €50 million to invest, Italian Founders Fund looks for entrepreneurs with global ambitions

William A. Anders, the astronaut behind perhaps the single most iconic photo of our planet, has died at the age of 90. On Friday morning, Anders was piloting a small…

William Anders, astronaut who took the famous ‘Earthrise’ photo, dies at 90

You’re running out of time to join the Startup Battlefield 200, our curated showcase of top startups from around the world and across multiple industries. This elite cohort — 200…

Startup Battlefield 200 applications close tomorrow

New York’s state legislature has passed a bill that would prohibit social media companies from showing so-called “addictive feeds” to children under 18, unless they obtain parental consent. The Stop…

New York moves to limit kids’ access to ‘addictive feeds’

Dogs are the most popular pet in the U.S.: 65.1 million households have one, according to the American Pet Products Association. But while cats are not far off, with 46.5…

Cat-sitting startup Meowtel clawed its way to profitability despite trouble raising from dog-focused VCs

Anterior, a company that uses AI to expedite health insurance approval for medical procedures, has raised a $20 million Series A round at a $95 million post-money valuation led by…

Anterior grabs $20M from NEA to expedite health insurance approvals with AI

Welcome back to TechCrunch’s Week in Review — TechCrunch’s newsletter recapping the week’s biggest news. Want it in your inbox every Saturday? Sign up here. There’s more bad news for…

How India’s most valuable startup ended up being worth nothing

If death and taxes are inevitable, why are companies so prepared for taxes, but not for death? “I lost both of my parents in college, and it didn’t initially spark…

Bereave wants employers to suck a little less at navigating death

Google and Microsoft have made their developer conferences a showcase of their generative AI chops, and now all eyes are on next week’s Worldwide Developers Conference, which is expected to…

Apple needs to focus on making AI useful, not flashy

AI systems and large language models need to be trained on massive amounts of data to be accurate but they shouldn’t train on data that they don’t have the rights…

Deal Dive: Human Native AI is building the marketplace for AI training licensing deals

Before Wazer came along, “water jet cutting” and “affordable” didn’t belong in the same sentence. That changed in 2016, when the company launched the world’s first desktop water jet cutter,…

Wazer Pro is making desktop water jetting more affordable

Former Autonomy chief executive Mike Lynch issued a statement Thursday following his acquittal of criminal charges, ending a 13-year legal battle with Hewlett-Packard that became one of Silicon Valley’s biggest…

Autonomy’s Mike Lynch acquitted after US fraud trial brought by HP

Featured Article

What Snowflake isn’t saying about its customer data breaches

As another Snowflake customer confirms a data breach, the cloud data company says its position “remains unchanged.”

3 days ago
What Snowflake isn’t saying about its customer data breaches

Investor demand has been so strong for Rippling’s shares that it is letting former employees particpate in its tender offer. With one exception.

Rippling bans former employees who work at competitors like Deel and Workday from its tender offer stock sale

It turns out the space industry has a lot of ideas on how to improve NASA’s $11 billion, 15-year plan to collect and return samples from Mars. Seven of these…

NASA puts $10M down on Mars sample return proposals from Blue Origin, SpaceX and others

Featured Article

In 2024, many Y Combinator startups only want tiny seed rounds — but there’s a catch

When Bowery Capital general partner Loren Straub started talking to a startup from the latest Y Combinator accelerator batch a few months ago, she thought it was strange that the company didn’t have a lead investor for the round it was raising. Even stranger, the founders didn’t seem to be…

3 days ago
In 2024, many Y Combinator startups only want tiny seed rounds — but there’s a catch

Welcome to Startups Weekly — Haje’s weekly recap of everything you can’t miss from the world of startups. Anna will be covering for him this week. Sign up here to…

Startups Weekly: Ups, downs, and silver linings

HSBC and BlackRock estimate that the Indian edtech giant Byju’s, once valued at $22 billion, is now worth nothing.

BlackRock has slashed the value of stake in Byju’s, once worth $22 billion, to zero

Apple is set to board the runaway locomotive that is generative AI at next week’s World Wide Developer Conference. Reports thus far have pointed to a partnership with OpenAI that…

Apple’s generative AI offering might not work with the standard iPhone 15

LinkedIn has confirmed it will no longer allow advertisers to target users based on data gleaned from their participation in LinkedIn Groups. The move comes more than three months after…

LinkedIn to limit targeted ads in EU after complaint over sensitive data use

Founders: Need plans this weekend? What better way to spend your time than applying to this year’s Startup Battlefield 200 at TechCrunch Disrupt. With Monday’s deadline looming, this is a…

Startup Battlefield 200 applications due Monday